Antimicrobial Susceptibility Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

The Antimicrobial Susceptibility Testing Market was valued at USD 2024 in 4.41 Billion, and is expected to reach USD 5.98 Billion by 2030, rising at a CAGR of 5.17%. The market is expanding significantly as antibiotic resistance becomes a pressing global health concern, prompting the need for accurate, timely diagnostic tools. AST plays a pivotal role in guiding clinicians toward appropriate antibiotic treatments, reducing therapy failure rates and curbing the misuse of antimicrobial agents. The growing prevalence of multidrug-resistant infections and the increased global awareness around antimicrobial resistance (AMR) have elevated the demand for reliable AST solutions. Advancements in rapid and automated diagnostic systems are accelerating adoption, particularly in hospitals and diagnostic laboratories. Additionally, integration of AI and machine learning into AST platforms is enhancing precision and efficiency, making AST an essential component of personalized and precision medicine.

Key Market Drivers

Increase in Prevalence of Infectious Diseases

The rising incidence of infectious diseases, including influenza, tuberculosis, pneumonia, and COVID-19, is significantly driving demand for antimicrobial susceptibility testing. As pathogens evolve and resistance increases, AST has become critical for selecting effective treatments and minimizing inappropriate antibiotic usage. For instance, COVID-19 underscored the need for robust diagnostic infrastructure to manage outbreaks and inform treatment protocols. Similarly, pneumonia remains a leading cause of mortality among children globally, particularly in low-income regions. AST helps clinicians identify suitable antimicrobials, thereby improving patient outcomes and reducing AMR risks. The growing dependence on AST for both routine and emergent infectious disease management continues to fuel market growth.

Key Market Challenges

Lack of Standardization and Validation

A major obstacle in the AST market is the absence of standardized procedures and validation protocols across different testing platforms and laboratories. The variation in testing methods can lead to inconsistent results, complicating clinical interpretation and undermining treatment efficacy. Without uniform guidelines, healthcare providers may struggle to compare susceptibility data across institutions or regions. The validation of new AST technologies is also resource-intensive, involving extensive trials to meet regulatory requirements. In developing regions, limited infrastructure and training further exacerbate the issue. These inconsistencies can delay adoption and hinder efforts to combat antimicrobial resistance effectively. Establishing global standards and robust validation processes is essential to address this challenge.

Key Market Trends

Shift Towards Automated and High-Throughput Systems

The global AST market is increasingly embracing automation and high-throughput platforms to meet rising diagnostic demand. Automated AST systems offer faster turnaround times, higher accuracy, and improved workflow efficiency, making them ideal for high-volume clinical settings. These systems reduce human error and enable large-scale sample processing, essential for timely identification of effective therapies. Integration with laboratory information systems (LIS) allows seamless data management and reporting. High-throughput capabilities are particularly critical as healthcare facilities face increasing caseloads due to infectious diseases and AMR. This trend toward automation is reshaping the diagnostic landscape, providing scalable, reliable solutions for modern healthcare environments.

Key Market Players

• Bio-Rad Laboratories Inc.
• Merck & Co., Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• bioMérieux SA
• Becton, Dickinson and Company
• ELITech Group SAS
• F. Hoffmann-La Roche Ltd.
• Accelerate Diagnostics, Inc.
• HiMedia Laboratories Private Limited

Report Scope:

In this report, the Global Antimicrobial Susceptibility Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Antimicrobial Susceptibility Testing Market, By Product:

• Manual Tests
• MIC Strips
• Susceptibility Testing Disks
• Susceptibility Plates
• Automated Instruments
• Consumables & Media

Antimicrobial Susceptibility Testing Market, By Technique:

• Automated AST
• Etest Method
• Dilution
• Disk Diffusion
• Others

Antimicrobial Susceptibility Testing Market, By Application:

• Drug Development
• Susceptibility Testing
• Others

Antimicrobial Susceptibility Testing Market, By End User:

• Hospitals
• Diagnostic Laboratories
• Biotechnology & Pharmaceutical Companies
• Others

Antimicrobial Susceptibility Testing Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Antimicrobial Susceptibility Testing Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.